Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Metlifecare Ltd (MET) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013611
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and caring environment and continuum of care, among others. It also encourage families to take part in the decision making process. The center provides various amenities across its different villages. It provides care services through its independent villas and apartments, serviced apartments, rest homes and hospitals. The center owns and operates retirement villages in Kerikeri, Auckland, Hamilton, Bay of Plenty and Lower North Island, among others. Metlifecare is headquartered in Auckland, New Zealand.

Metlifecare Ltd (MET) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Metlifecare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Metlifecare Completes Private Placement Of Shares For US$56.6 Million 9
Metlifecare Completes Rights Offering Of Common Stock For US$4.5 Million 10
Metlifecare Completes Private Placement Of Common Stock For US$32 Million 11
Acquisition 13
Retirement Villages Completes Sale Of 37.7% Stake In Metlifecare To Infratil And New Zealand Superannuation Fund For US$235 Million 13
Metlifecare Completes Acquisition Of Two Healthcare Service Providers For US$73 Million 15
Metlifecare Ltd – Key Competitors 17
Metlifecare Ltd – Key Employees 18
Metlifecare Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 28, 2017: Metlifecare Reports Record Profit And Substantial Development Growth 20
Corporate Communications 22
Jul 18, 2017: Metlifecare Appoints New Directors 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Metlifecare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Metlifecare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Metlifecare Completes Private Placement Of Shares For US$56.6 Million 9
Metlifecare Completes Rights Offering Of Common Stock For US$4.5 Million 10
Metlifecare Completes Private Placement Of Common Stock For US$32 Million 11
Retirement Villages Completes Sale Of 37.7% Stake In Metlifecare To Infratil And New Zealand Superannuation Fund For US$235 Million 13
Metlifecare Completes Acquisition Of Two Healthcare Service Providers For US$73 Million 15
Metlifecare Ltd, Key Competitors 17
Metlifecare Ltd, Key Employees 18
Metlifecare Ltd, Other Locations 19

★海外企業調査レポート[Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lixte Biotechnology Holdings Inc (LIXT):製薬・医療:M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tilaknagar Industries Ltd.:企業の戦略・SWOT・財務情報
    Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sapience Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sapience Therapeutics Inc (Sapience) is a preclinical-stage biotechnology company that focuses on developing novel therapeutics for major unmet medical needs with special emphasis on high mortality cancers. The company offers peptides that act at the level of transcriptional regulation of on …
  • Westrock Co:企業の戦略・SWOT・財務分析
    Westrock Co - Strategy, SWOT and Corporate Finance Report Summary Westrock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Kiyo Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Kiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Kiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Melinta Therapeutics Inc (MLNT):企業の財務・戦略的SWOT分析
    Melinta Therapeutics Inc (MLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • WSI Industries, Inc.:企業の戦略・SWOT・財務分析
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Crescent Point Energy Corp (CPG):企業の財務・戦略的SWOT分析
    Crescent Point Energy Corp (CPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Etex Group Sa:企業の戦略・SWOT・財務分析
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • HTC Corporation:企業の戦略・SWOT・財務情報
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Canara Bank (CANBK):企業の財務・戦略的SWOT分析
    Canara Bank (CANBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nodak Electric Cooperative, Inc.:発電所・企業SWOT分析
    Nodak Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Pacific & Orient Berhad:企業の戦略・SWOT・財務分析
    Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report Summary Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Active Biotech AB (ACTI)-製薬・医療分野:企業M&A・提携分析
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed o …
  • Mitsubishi Materials Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Materials Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Materials Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Fisia Italimpianti SpA:企業の戦略的SWOT分析
    Fisia Italimpianti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆